Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
CA Stock MarketDetailed Quotes
EPRX Eupraxia Pharmaceuticals Inc
- 5.510
- +0.010+0.18%
15min DelayMarket Closed May 2 16:00 ET
197.53MMarket Cap-5.04P/E (TTM)
5.550High5.480Low11.31KVolume5.520Open5.500Pre Close62.33KTurnover6.49052wk High0.05%Turnover Ratio35.85MShares3.07052wk Low-1.093EPS TTM137.29MFloat Cap9.100Historical HighLossP/E (Static)24.92MShs Float0.800Historical Low-1.093EPS LYR1.27%Amplitude--Dividend TTM84.77P/B1Lot Size--Div YieldTTM
About Eupraxia Pharmaceuticals Inc Company
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.
Company Profile
SymbolEPRX
Company NameEupraxia Pharmaceuticals Inc
Founded2011
MarketTSE
Employees33
Fiscal Year Ends12-31
Address201 2067 Cadboro Bay Road
CityVictoria
CountryCAN
Zip Code V8R 5G4
Phone+1 250 590-3968
Company Executives
- Name
- Position
- Salary
- Dr. James A. Helliwell, M.D.
- Chief Executive Officer and Director
- 517.30K
- Paul Brennan
- Chief Business Officer
- 343.12K
- Bruce G. Cousins
- Chief Financial Officer and President
- 368.72K
- Dr. Mark Kowalski, M.D.,Pd.D
- Chief Medical Officer
- 988.79K
- Dr. Amanda Malone
- Chief Scientific Officer and Chief Operating Officer
- 368.72K
- Dr. Simon Pione, F.R.C.P.C,M.D.,PhD
- Chairman of the Board
- 42.23K
- Paul L. Geyer, P. Eng.
- Independent Director
- 23.56K
- John S. Montalbano, C.F.A.
- Independent Director
- 29.86K
- Dr. Richard M. Glickman,L.L.D.
- Independent Director
- 29.86K
- Dr. Michael Wilmink, M.D.
- Independent Director
- 23.56K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts